SMN-knockdown in NSC34 cells demonstrated its efficient down-regulation similar to levels observed in primary fibroblasts derived from type-1 SMA patients ([36], Fig. 3B). This evidence concerns the gene SMN1 and spinal muscular atrophy, type 1.